NASDAQ:IMCR | Free Cash Flow | Immunocore Holdings plc

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2021-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$13.78M$1.78M-$15.56M-119.93%
2025-12-31-$32.66M$2.88M-$35.54M
2025-03-31$435,000.00$298,000.00$137,000.002.73%
2024-12-31-$13.95M$3.58M-$17.54M
2024-03-31-$4.59M$430,000.00-$5.02M
2023-12-31-$17.73M$817,000.00-$18.55M
2023-03-31$10.54M$3M$7.54M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$10.71M$4.34M-$15.05M
2024-12-31$26.06M$5.17M$20.89M
2023-12-31$2.94M$5.43M-$2.49M
2022-12-31-$49.21M$2.2M-$51.41M
2021-12-31-$143.11M$1.39M-$144.49M